People with multiple sclerosis can help prevent shingles and its complications with the Shingrix vaccine. Review the benefits and risks. Shingrix is a vaccine that protects against shingles—a painful rash caused by the reactivation of the same virus that causes chicken pox. People with multiple sclerosis (MS) may wonder if it’s safe to get the shingles vaccine. fstop123 / Getty
Shingrix is a vaccine that protects against shingles—a painful rash caused by the reactivation of the same virus that causes chicken pox. People with multiple sclerosis (MS) may wonder if it’s safe to get the shingles vaccine.
fstop123 / Getty Images
Multiple sclerosis is a disease that damages the central nervous system. This damage leads to symptoms like muscle weakness, blurred vision, memory loss, and problems with balance and coordination. MS is most likely an autoimmune disorder, which means that it causes the body to attack its own healthy tissues.
MS medicines may reduce the effectiveness of various vaccines. The best timing for getting the shingles vaccine can also depend on your MS disease activity.
Learn about getting the shingles vaccine with MS, including risks, benefits, side effects, and more.
Shingles (herpes zoster, or HZ) is a condition that causes a painful rash and blisters, often on only one side of the body or face. Other symptoms may include fever, fatigue, headache, and nausea.
Shingles is caused by a reactivation of the varicella-zoster virus (VZV), the virus that causes chicken pox. About one in three people in the United States will develop shingles during their lifetime.
Shingrix (recombinant zoster vaccine, or RZV)—the shingles vaccine—is used to prevent shingles and related medical complications in older and immunocompromised adults. It is usually delivered in two doses in the upper arm muscle, two to six months apart.
According to the Centers for Disease Control and Prevention (CDC), all people over 50 years old and immunocompromised adults over 19 years old should get two doses of Shingrix. This recommendation includes people with MS.
However, a few considerations that people with MS should take into account when getting Shingrix or any other vaccine are:
Immunosuppressants, sometimes called immunosuppressive drugs, are medicines that work by controlling the body’s immune response. This means they control or “calm down” natural defense mechanisms.
While immunosuppressants can help to treat certain medical conditions, they also increase the risk of infections and other health complications.
Shingrix was approved by the Food and Drug Administration (FDA) in 2017 to prevent shingles and related complications. Previously, the only available shingles vaccine in the United States was Zostavax (zoster vaccine live).
Zostavax is a live vaccine, which means it contains a weakened version of the virus that causes shingles. People with MS who are taking a disease-modifying therapy (DMT) should typically avoid live vaccines. Since 2020, Zostavax has not been available for use in the United States.
Shingrix is a recombinant vaccine, meaning that it is made out of only a specific piece of the virus. Recombinant vaccines like Shingrix are typically safe for people with MS, even those who are taking a DMT.
The most common shingles complication is postherpetic neuralgia (PHN)—severe, long-term nerve pain in the area of the initial rash. In rare cases, shingles can lead to pneumonia, vision problems, hearing loss, hospitalization, and even death. Adults over 50 years old and people with weakened immune systems are particularly at risk for shingles complications.
The shingles vaccine is safe and effective for most people, including people with MS. Among people over 50 with fully functioning immune systems, Shingrix is 97% effective in preventing shingles and 91% effective in preventing PHN. Among people with weakened immune function, Shingrix is 68%–91% effective.
Because they often have a weakened immune system, people with MS are more likely to develop infections and other illnesses. Vaccination is a crucial part of preventing infection and hospitalization among people with MS.
While there appears to be a link between shingles and MS, it is not yet entirely understood by researchers.
Here are some recent findings about the association between HZ and MS symptoms:
Studies indicate that Shingrix is effective in lowering the risk of shingles in people with MS—without causing dangerous side effects. Recent research suggests that most people with MS should get the shingles vaccine, even people who are taking low-dose immunosuppressive medications.
People who are immunocompromised, or immunosuppressed, have a weakened immune system. This reduces their body’s ability to defend itself against illnesses and infections. Some people are immunocompromised by a disease, such as cancer, kidney failure, or diabetes. Others are immunocompromised by certain drugs, surgeries, or therapies.
It’s safe for most people, including people with MS, to get two doses of Shingrix. However, there are a few exceptions.
According to the CDC, you should not get the shingles vaccine if you:
If you have a mild illness, such as a cold or flu, you can still get your scheduled dose of Shingrix. If you’re severely ill or have a high fever, you should hold off until you feel better.
As you discuss the shingles vaccine with your healthcare provider, here are a few things to consider if you have MS:
The most common side effects from Shingrix are pain, redness, and/or swelling at the site of injection. Other common side effects include headache, nausea, muscle pain, fatigue, fever, and trembling.
Most Shingrix side effects are mild and go away on their own within two to three days. If your side effects don’t go away or start to get worse, tell your healthcare provider right away.
In rare cases, Shingrix may cause a severe allergic reaction. Signs of a severe allergic reaction to Shingrix include hives, light-headedness, difficulty breathing, and facial swelling. Seek immediate medical help if you think you are experiencing an allergic reaction to the shingles vaccine.
If you have MS and are thinking of getting the shingles vaccine, here are a few topics to discuss with your healthcare provider or medical team:
Multiple sclerosis (MS) is an autoimmune disease that damages the central nervous system. Certain vaccines may be less effective in people with MS because of the medicines they take to control their symptoms.
Shingrix (the recombinant zoster vaccine, or RZV) is a two-dose vaccine that works to prevent shingles (herpes zoster) and related complications in adults ages 50 and older, as well as immunocompromised adults ages 19 and over. Shingrix is safe and effective for most people with MS.
However, people with MS who are taking immunosuppressive drugs should tell their healthcare provider before getting Shingrix. Their healthcare provider may offer them a Shingrix dose earlier or later, depending on their scheduled treatment.
People who are currently having an MS flare-up should wait until their symptoms are under control to take the shingles vaccine.
If you have MS, vaccination is an important way you can protect your long-term health. Before getting the shingles vaccine, talk to your healthcare provider about your current symptoms, the medications you’re taking, and any other concerns you may have.
Yes. The CDC recommends that all adults ages 50 and older, as well as immunocompromised adults ages 19 and older, get two doses of Shingrix to prevent shingles and related complications.
Research suggests that the shingles vaccine is safe and effective for people with multiple sclerosis (MS). However, people who are currently taking or planning to take immunosuppressive medicines to treat their MS should tell their healthcare provider before getting Shingrix.
People with MS who are having a severe flare-up of their symptoms should also wait to get the vaccine.
Maybe. Some studies suggest that both chicken pox and shingles may increase the risk of developing MS and worsen existing MS symptoms. However, this evidence is still controversial and limited. Other research suggests that having MS can increase the risk of contracting shingles and developing shingles-related complications.
Usually not. Typically, people with MS who are taking disease-modifying therapies (DMTs) should not take live vaccines. If someone with MS is taking, has recently taken, or is about to start taking any medication that suppresses the immune system, they might need to wait to get a live vaccine.
Shingrix is not a live vaccine. People with MS who are severely ill or who are currently having a flare-up should talk to their healthcare provider before getting any vaccine.